Discovery Labs Shareholders Get Smacked on Secondary Offering (DSCO)
Respiratory drug maker Discovery Laboratories Inc. (NASDAQ: DSCO) priced a secondary offering of slightly more than 16 million shares this morning, and the stock is getting pummeled as a result. ...Read Full Story »


